RBM7
RNA-binding protein 7
Also known as: RBM7_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y580
- Gene
- RBM7
- Ensembl
- ENSG00000076053
- Chromosome
- 11
- Canonical length
- 266 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables 14-3-3 protein binding activity; pre-mRNA intronic binding activity; and snRNA binding activity. Involved in snRNA catabolic process. Located in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
266 residues, UniProt reviewed canonical sequence.
>Q9Y580|RBM7
1 MGAAAAEADR TLFVGNLETK VTEELLFELF HQAGPVIKVK IPKDKDGKPK QFAFVNFKHE
61 VSVPYAMNLL NGIKLYGRPI KIQFRSGSSH APQDVSLSYP QHHVGNSSPT STSPSRYERT
121 MDNMTSSAQI IQRSFSSPEN FQRQAVMNSA LRQMSYGGKF GSSPLDQSGF SPSVQSHSHS
181 FNQSSSSQWR QGTPSSQRKV RMNSYPYLAD RHYSREQRYT DHGSDHHYRG KRDDFFYEDR
241 NHDDWSHDYD NRRDSSRDGK WRSSRHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RBM7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 38 nTPM
- liver: 17 nTPM
- thymus: 14 nTPM
- tongue: 14 nTPM
- ovary: 13 nTPM
- breast: 12 nTPM
Single-cell type
- cardiomyocytes: 64 nCPM
- adipocytes: 20 nCPM
- early spermatids: 14 nCPM
- epicardial cells: 14 nCPM
- late primary spermatocytes: 9.5 nCPM
- endometrial secretory cells: 7.1 nCPM
Immune cell
- basophil: 53 nTPM
- eosinophil: 18 nTPM
- NK-cell: 17 nTPM
- non-classical monocyte: 17 nTPM
- classical monocyte: 15 nTPM
- MAIT T-cell: 15 nTPM
Brain region
- cerebellum: 18 nTPM
- medulla oblongata: 16 nTPM
- white matter: 16 nTPM
- basal ganglia: 14 nTPM
- hypothalamus: 14 nTPM
- spinal cord: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.52
- gnomAD pLI
- 0.65
- gnomAD missense Z
- 0.83
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RBM7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RBM7 as an antibody target. Whether an autoantibody or antibody against RBM7 could matter depends on whether native RBM7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RBM7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RBM7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...